Salyrgan theophylline supplier

Name
sodium [3-({[2-(carboxylatomethoxy)phenyl]carbonyl}amino)-2-methoxypropyl]mercury - 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1) hydrate
EINECS
CAS No. 7681-34-7
Density g/cm³
Solubility
Melting Point
Formula (C₁₃H₁₇HgNNaO₆)_n•C₇H₈N₄O₂
Boiling Point °Cat760mmHg
Molecular Weight 687.021
Flash Point °C
Transport Information
Appearance
Safety A poison by subcutaneous, intramuscular, and intravenous routes. When heated to decomposition it emits very toxic fumes of Hg, Na₂O, and NO_x. See also MERCURY COMPOUNDS, INORGANIC; MERCURY COMPOUNDS, ORGANIC and THEOPHYLLINE.
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms
PSA
LogP

Salyrgan theophylline Chemical Properties

Molecule structure of Salyrgan theophylline (CAS NO.7681-34-7) :

IUPAC Name: sodium; 1,3-dimethyl-7H-purine-2,6-dione; [2-methoxy-3-[[2-(2-oxido-2-oxoethoxy)benzoyl]amino]propyl]mercury;hydrate
Molecular Weight: 687.02097 g/mol
Molecular Formula: C₂₀H₂₅HgN₅NaO₈
H-Bond Donor: 3
H-Bond Acceptor: 9
Rotatable Bond Count: 9
Tautomer Count: 6
Exact Mass: 688.130708
MonoIsotopic Mass: 688.130708
Topological Polar Surface Area: 158
Heavy Atom Count: 35
Complexity: 601
Canonical SMILES: CN1C2=C(C(=O)N(C1=O)C)NC=N2.COC(CNC(=O)C1=CC=CC=C1OCC(=O)[O-])C[Hg].O.
[Na+]
InChI: InChI=1S/C13H16NO5.C7H8N4O2.Hg.Na.H2O/c1-9(18-2)7-14-13(17)10-5-3-4-6-11(10)19-8-12(15)16;1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;;;/h3-6,9H,1,7-8H2,2H3,(H,14,17)(H,15,16);3H,1-2H3,(H,8,9);;;1H2/q;;;+1;/p-1
InChIKey of Salyrgan theophylline (CAS NO.7681-34-7) : UYBFTPVNECIZCO-UHFFFAOYSA-M

Salyrgan theophylline Toxicity Data With Reference

1.	scu-rat LD50:14 mg(Hg)/kg	JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394.
2.	ims-rat LD50:8 mg(Hg)/kg	JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394.
3.	scu-mus LD50:87 mg(Hg)/kg	JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394.
4.	ivn-mus LD50:950 mg/kg	JPETAB Journal of Pharmacology and Experimental Therapeutics. 99 (1950),149.
5.	ivn-ham LD50:11 mg(Hg)/kg	JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394.

Salyrgan theophylline Consensus Reports

Mercury and its compounds are on the Community Right-To-Know List.

Salyrgan theophylline Safety Profile

A poison by subcutaneous, intramuscular, and intravenous routes. When heated to decomposition it emits very toxic fumes of Hg, Na₂O, and NO_x. See also MERCURY COMPOUNDS, INORGANIC; MERCURY COMPOUNDS, ORGANIC and THEOPHYLLINE.

Salyrgan theophylline Standards and Recommendations

OSHA PEL: CL 0.1 mg(Hg)/m³ (skin)
ACGIH TLV: TWA 0.1 mg(Hg)/m³ (skin); BEI: 35 µg/g creatinine total inorganic mercury in urine preshift; 15 µg/g creatinine total inorganic mercury in blood at end of shift at end of workweek.
DFG MAK: Confirmed Animal Carcinogen with Unknown Relevance to Humans
NIOSH REL: (Mercury, Aryl and Inorganic) CL 0.1 mg/m³ (skin)

Salyrgan theophylline Specification

Salyrgan theophylline (CAS NO.7681-34-7) is also called Mersalyl with theophylline ; Mersalyl-theophylline mixt. ; Mercury, (3-(o-(carboxymethoxy)benzamido)-2-methoxypropyl)hydroxy-, monosodium salt, compd. with theophylline .

Product Name

sodium [3-({[2-(carboxylatomethoxy)phenyl]carbonyl}amino)-2-methoxypropyl]mercury - 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1) hydrate